Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shandong Pharmaceutical Glass Co has a current ratio of 3.79. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Shandong Pharmaceutical Glass Co's Current Ratio or its related term are showing as below:
SHSE:600529'
s Current Ratio Range Over the Past 10 Years
Min: 1.93 Med: 2.88 Max: 3.79
Current: 3.79
During the past 13 years, Shandong Pharmaceutical Glass Co's highest Current Ratio was 3.79. The lowest was 1.93. And the median was 2.88.
SHSE:600529's Current Ratio is ranked better than 86.28% of 401
companies
in the Packaging & Containers industry
Industry Median: 1.7
vs SHSE:600529: 3.79
Shandong Pharmaceutical Glass Co (SHSE:600529) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Shandong Pharmaceutical Glass Co Current Ratio Related Terms
Shandong Pharmaceutical Glass Co Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Pharmaceutical Glass Co Current Ratio Chart
SHSE:600529 vs SW, PKG, IP: Current Ratio Comparison
For the Packaging & Containers subindustry, Shandong Pharmaceutical Glass Co's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shandong Pharmaceutical Glass Co Current Ratio vs Packaging & Containers Industry
For the Packaging & Containers industry and Consumer Cyclical sector, Shandong Pharmaceutical Glass Co's Current Ratio distribution charts can be found below:
* The bar in red indicates where Shandong Pharmaceutical Glass Co's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Pharmaceutical Glass Co (SHSE:600529) has a Current Ratio of 3.79 as of Mar. 2026. This is 32% above median its historical median of 2.88. Over the past decade, Shandong Pharmaceutical Glass Co's Current Ratio has ranged from 1.93 to 3.79. According to the industry distribution chart, Shandong Pharmaceutical Glass Co ranks #55 out of 401 companies in the Packaging & Containers industry, placing it in the top 13.7%.
Is Shandong Pharmaceutical Glass Co's Current Ratio too high?
Shandong Pharmaceutical Glass Co's current Current Ratio of 3.79 is 32% above median its 10-year median of 2.88. Over the past 10 years, this metric has ranged from a low of 1.93 to a high of 3.79. The Packaging & Containers industry median Current Ratio is 1.70. Shandong Pharmaceutical Glass Co's value of 3.79 is 122.9% above this industry median. Based on the distribution chart, Shandong Pharmaceutical Glass Co ranks #55 out of 401 companies in the Packaging & Containers industry, which is in the top quartile — a strong position relative to peers. Overall, Shandong Pharmaceutical Glass Co has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shandong Pharmaceutical Glass Co's Current Ratio compare to SW and PKG?
According to the Packaging & Containers industry distribution chart, Shandong Pharmaceutical Glass Co ranks #55 out of 401 companies for Current Ratio. This places Shandong Pharmaceutical Glass Co in the top 14% of its industry — outperforming the majority of peers. The industry median Current Ratio is 1.70. Shandong Pharmaceutical Glass Co's value of 3.79 is 122.9% above this benchmark. Historically, Shandong Pharmaceutical Glass Co's own Current Ratio has ranged from 1.93 to 3.79 over the past decade. While the company's 10-year median is 2.88 vs. the industry median of 1.70, Shandong Pharmaceutical Glass Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Packaging & Containers company?
The median Current Ratio among Packaging & Containers companies is 1.70, based on 401 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shandong Pharmaceutical Glass Co's current Current Ratio of 3.79 is 122.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Packaging & Containers industry, the median Current Ratio is 1.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shandong Pharmaceutical Glass Co's current Current Ratio is 3.79, which is 32% above median its own 10-year median of 2.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Pharmaceutical Glass Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Pharmaceutical Glass Co (SHSE:600529) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥24.20, compared to a current price of ¥18.71 — trading 22.7% below its estimated fair value. The current Current Ratio is 3.79, which is 32% above median its 10-year median of 2.88 and 122.9% above the Packaging & Containers industry median of 1.70. Shandong Pharmaceutical Glass Co's overall GF Score™ is 89/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Shandong Pharmaceutical Glass Co (SHSE:600529), the current Current Ratio is 3.79 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shandong Pharmaceutical Glass Co (SHSE:600529) Overvalued in 2026?
Based on GuruFocus' analysis, Shandong Pharmaceutical Glass Co stock appears to be undervalued.
The current stock price of ¥18.71 is trading 22.7% below its estimated GF Value™ of ¥24.20.
GuruFocus considers Shandong Pharmaceutical Glass Co to be Modestly Undervalued.
Key valuation signals for SHSE:600529:
Current Ratio: 3.79 (32% above median its 10-year median of 2.88)
GF Value™: ¥24.20 vs. price of ¥18.71 (22.7% below fair value)
Industry Position: 122.9% above the Packaging & Containers median (#55 of 401)
No single metric tells the full story. See the SHSE:600529 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shandong Pharmaceutical Glass Co Business Description
Shandong Pharmaceutical Glass Co Ltd is a pharmaceutical glass packaging product company. Its pharmaceutical glass packaging products and butyl rubber series products which service object of pharmaceutical, food, daily necessities industries. The products include for moulded injection vial for antibiotics series, tubular glass vial series, amber glass bottle series, neutral borosilicate glass bottle series, infusion bottle series, cosmetic bottles series, food bottles series, butyl rubber stopper series, prefillable syringes series, and aluminum-plastic cap series.
89GF Score
Get the complete analysis for SHSE:600529
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600529 has been successfully added to your 
